🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Multidrug- and Rifampicin-resistant Tuberculosis

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis NCT06590428NA1 site📍 East London Albert Einstein College of Medicine · Tests: Therapeutic Drug Monitoring for Linezolid A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis NCT07209761Phase 342 sites📍 Beijing📍 Fuzhou📍 Shenzhen Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: Bedaquiline, Quabodepistat, Pretomanid, Moxifloxacin, Linezolid Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) NCT05534750Phase 21 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard quadruple therapy arm Bioneer Q-RFIA Clinical Evaluation NCT05117788n/a5 sites📍 Nairobi📍 Chisinau📍 Lima Foundation for Innovative New Diagnostics, Switzerland · Tests: Estimate the diagnostic accuracy of the Bioneer Accupower Q-RFIA PCR kit on IRON qPCR for MTB detection using culture a… A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets NCT07170800Phase 27 sites📍 Wuhan📍 Changsha📍 Nanjing WestVac Biopharma Co., Ltd. · Tests: JDB0131 100mg, JDB0131 200mg, Delamanid (D) A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients NCT05824871Phase 32 sites📍 Beijing📍 Beijing Shanghai Jiatan Pharmatech Co., Ltd · Tests: Sudapyridine, Bedaquiline Novel Triple-dose Tuberculosis Retreatment Regimen NCT04260477Phase 31 site📍 Niamey Institute of Tropical Medicine, Belgium · Tests: 6EH³R³Z, 6EHRZ Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) NCT05081401Phase 35 sites📍 Guiyang📍 Kaili📍 Liupanshui Huashan Hospital · Tests: Bdq(Lzd)+Lfx(Mfx)+Cfz(Cs)+Pto+E+H+Z, A1, A2a, A2b, A2c Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment NCT05671718NA5 sites📍 Pietermaritzburg📍 Port Shepstone📍 East London Johns Hopkins University · Tests: Nurse-Led Treatment in Primary Care Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis NCT06441006Phase 2, Phase 36 sites📍 Ulaanbaatar📍 Kotri📍 Lima University of California, San Francisco · Tests: Bedaquiline, Linezolid, Pretomanid, Moxifloxacin, Control Arm FQ-S MDR/RR-TB regimen, designed according to latest inte… BPaL(M) Regimen for the Treatment of MDR/RR-TB NCT05381194Phase 41 site📍 Seoul Asan Medical Center · Tests: BPaL(M) regimen
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy